Skip to content
Signal / glp-1
  • Reviews
  • Best of
  • Compare
  • Guides
  • Methodology
See the reviews
Home

5 comparison pages · updated 2026-08-14

Comparisons

The choices that actually change what you pay and what you get — molecule against molecule, approved against compounded, and all thirteen services in one table.

Comparison

Semaglutide vs tirzepatide

One targets a single receptor, the other two. The trial averages differ by about six percentage points of body weight — and the cheaper one to buy is not the more effective one.

5 sources · updated 2026-08-14

Read

Comparison

Brand-name vs compounded GLP-1s

The price gap is real and large. So is the difference in what has been reviewed, what is in the vial, and who does the dose arithmetic.

18 sources · updated 2026-08-14

Read

Comparison

Every researched GLP-1 provider, side by side

One table, seventy-seven services across the US and UK, all verified figures. Sort it by whichever column is the one that actually decides it for you.

19 sources · updated 2026-08-14

Read

Comparison

Same molecule, different label, ten times the price

Ozempic and Wegovy are both semaglutide. Mounjaro and Zepbound are both tirzepatide. The manufacturers say so, and price them as if they were different drugs.

14 sources · updated 2026-08-15

Read

Reference

Every GLP-1 brand, and what each one is licensed for

Nine brand names, five molecules, two different jobs. This is the whole approved set, with what each is actually licensed to treat and which ones are going away.

12 sources · updated 2026-08-15

Read

Signal / glp-1

GLP-1 reviews, without the sales pitch. Scores come from a published rubric applied identically to every service, and the working is shown on each provider page.

Research

  • Provider reviews
  • Best-of guides
  • Comparisons
  • Guides

Medications

  • Tirzepatide
  • Semaglutide
  • Orforglipron
  • Liraglutide
  • Dulaglutide
  • How we score

Not medical advice

Everything here is journalism about medicines and the services that sell access to them. It is not a diagnosis, not a prescription, and not a substitute for a clinician who knows your history. GLP-1 medicines carry a boxed warning and real contraindications. Decisions about starting, changing or stopping one belong with a qualified professional.

Market scope: Primarily the United States, with a UK section. US prices are USD and refer to the FDA; UK prices are GBP and refer to the MHRA. Every provider page states which market it covers. · Last reviewed 2026-08-14